BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2487569)

  • 21. Renal transplantation at the University of Wisconsin in the cyclosporine era.
    Knechtle SJ; Pirsch JD; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
    Clin Transpl; 1993; ():211-8. PubMed ID: 7918154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The UNOS Scientific Renal Transplant Registry.
    Cecka JM; Terasaki PI
    Clin Transpl; 1993; ():1-18. PubMed ID: 7918142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
    Shield CF
    Clin Transpl; 1990; ():265-74. PubMed ID: 2129408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ; First MR; Mansour ME; Alexander JW; Penn I
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients.
    Thistlethwaite JR; Heffron TG; Stuart JK; Buckingham M; Stuart FP
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):28-34. PubMed ID: 2510508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cadaveric renal transplantation in the cyclosporine and OKT3 eras: the University of Wisconsin-Madison experience.
    Stratta RJ; Armbrust MJ; Lorentzen DF; Hoffman RM; D'Alessandro AM; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Clin Transpl; 1987; ():183-93. PubMed ID: 3154400
    [No Abstract]   [Full Text] [Related]  

  • 33. Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner A; Sutherland DE
    Clin Transpl; 1996; ():47-67. PubMed ID: 9286558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single center experience with cyclosporine in renal transplantation: Ohio State University 1983 to 1987.
    Ferguson RM; Henry ML; Sommer BG; Sachs L; Orosz CG
    Clin Transpl; 1987; ():195-207. PubMed ID: 3154402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival of kidney allografts.
    Cook DJ
    Clin Transpl; 1987; ():277-85. PubMed ID: 3154418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eurotransplant. Part II. The cyclosporine era 1981-1985.
    Persijn GG; de Lange P; D'Amaro J; Cohen B; Liebelt P; Hendriks GF; van Rood JJ
    Clin Transpl; 1986; ():99-107. PubMed ID: 3154458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive regimens and their effects on renal allograft outcome.
    Katznelson S; Cecka JM
    Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transfusion effect.
    Cecka M; Toyotome A
    Clin Transpl; 1989; ():335-41. PubMed ID: 2487601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.